U.S., Sept. 16 -- ClinicalTrials.gov registry received information related to the study (NCT07820891) titled 'A Trial in Healthy Participants to Assess Drug Interaction Potential of BGB-43395' on Sept. 10.
Brief Summary: This study will enroll healthy participants to evaluate whether BGB-43395 interacts with other drugs, including midazolam, celecoxib, dabigatran, and rosuvastatin.
Study Start Date: Sept. 24
Study Type: INTERVENTIONAL
Condition:
Healthy Adult Participants
Intervention:
DRUG: BGB-43395
Administered orally
DRUG: Midazolam
Administered orally
DRUG: Celecoxib
Administered orally
DRUG: Dabigatran etexilate
Administered orally
DRUG: Rosuvastatin
Administered orally
Recruitment Status: NOT_YET_RECRUITING
Sponsor:...